These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. The role of generics in kidney transplant: mycophenolate mofetil 500 versus mycophenolate: 2-year results. Abdallah TB; Ounissi M; Cherif M; Helal I; Karoui C; Mhibik S; Bacha MM; Abderrahim E; Kheder A Exp Clin Transplant; 2010 Dec; 8(4):292-6. PubMed ID: 21143094 [TBL] [Abstract][Full Text] [Related]
24. A blinded, long-term, randomized multicenter study of mycophenolate mofetil in cadaveric renal transplantation: results at three years. Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group. Mathew TH Transplantation; 1998 Jun; 65(11):1450-4. PubMed ID: 9645801 [TBL] [Abstract][Full Text] [Related]
25. Pharmacoeconomic analysis of mycophenolate mofetil versus azathioprine in primary cadaveric renal transplantation. Baker GM; Martin JE; Jang R; Schroeder TJ; Armitstead JA; Myre S; First MR Transplant Proc; 1998 Dec; 30(8):4082-4. PubMed ID: 9865304 [No Abstract] [Full Text] [Related]
26. The use of mycophenolate mofetil in liver transplant recipients. Detry O; de Roover A; Delwaide J; Meurisse M; Honoré P Expert Opin Pharmacother; 2003 Nov; 4(11):1949-57. PubMed ID: 14596648 [TBL] [Abstract][Full Text] [Related]
27. Effect of mycophenolate mofetil on the prevention of acute renal allograft rejection. Miladipour AH; Ghods AJ; Nejadgashti H Transplant Proc; 2002 Sep; 34(6):2089-90. PubMed ID: 12270325 [No Abstract] [Full Text] [Related]
28. Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection. European Mycophenolate Mofetil Cooperative Study Group. Lancet; 1995 May; 345(8961):1321-5. PubMed ID: 7752752 [TBL] [Abstract][Full Text] [Related]
29. Mycophenolate mofetil: a pharmacoeconomic review of its use in solid organ transplantation. Young M; Plosker GL Pharmacoeconomics; 2002; 20(10):675-713. PubMed ID: 12162756 [TBL] [Abstract][Full Text] [Related]
30. Mycophenolate mofetil: a unique immunosuppressive agent. Hood KA; Zarembski DG Am J Health Syst Pharm; 1997 Feb; 54(3):285-94. PubMed ID: 9028422 [TBL] [Abstract][Full Text] [Related]
32. Mycophenolate mofetil versus azathioprine in organ transplantation. Cravedi P; Perna A; Ruggenenti P; Remuzzi G Am J Transplant; 2009 Dec; 9(12):2856-7. PubMed ID: 19845579 [No Abstract] [Full Text] [Related]
33. Enteric-coated mycophenolate sodium: a review of its use in the prevention of renal transplant rejection. Sanford M; Keating GM Drugs; 2008; 68(17):2505-33. PubMed ID: 19016576 [TBL] [Abstract][Full Text] [Related]
34. Postmarketing evaluation of mycophenolate mofetil-based triple therapy immunosuppression compared with a conventional azathioprine-based regimen reveals enhanced efficacy and early pharmacoeconomic benefit after renal transplantation. Wüthrich RP; Weinreich T; Schwarzkopf AK; Candinas D; Binswanger U Transplant Proc; 1998 Dec; 30(8):4096-7. PubMed ID: 9865310 [No Abstract] [Full Text] [Related]